ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_1512 # 1281438 # 1281584 # -1 # ID=1_1512;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	scaffold_1_1512 	1281438	1281584	-	Strict	700	20.4014	OCH-3	100.0	3002516	protein homolog model	n/a	n/a	monobactam; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	OCH beta-lactamase	ATGGAGCTAGCGTACATCCCATCGCAACCGAGCGCCGATGAATCCCCAAGCGTAGAAGAGGAATTGAGTGAAGAACAGGAGCGACTTCAGAAATTAGTAGAGGCGCTAGAAGATGAAACTGATTGTGTTCGAGTGTGGACAACATAA	MELAYIPSQPSADESPSVEEELSEEQERLQKLVEALEDETDCVRVWTT	MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITIDGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFTLSDPATKWAPELADSSFDKITMLDLGTYTPGGLPLQFPDAVSDDSSMLAYFKKWKPDYPAGTQRRYSNPSIGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSGGALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYRVDANNQGLGWEFYNYPTALKTLLEGNSSDMALKSHKIEKFDTPSQPSADVWLNKTGSTNGFGAYAAFIPAKKIGIVLLANRNYPIDERVKAAYRILQALDNKQ	12.31	gnl|BL_ORD_ID|186|hsp_num:0	201	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_2547 # 2064602 # 2065003 # 1 # ID=1_2547;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.418	scaffold_1_2547 	2064602	2065003	+	Strict	500	23.0978	ADC-58	100.0	3004618	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGAATAATTGTAATCTACTCAATAGTCAACGAACTGTTGAAGGAGCATATTGCTCAAATGCATGCGTTTTCTCAGGTATGGCTAGTATTCTCCATGTCCAAGCCTTCCCCTTCTCCGATAGTGCTAGAAATTTCAACCCCCAGAAGTATCCTGAATTTTTTTTTCTCATGGGCCTTATAGAAAACTCTGACGAACAAGCAGTACGCCACGCAGAAGGCGAAGGGGTTGGTGAGGTAGAGCTCACGCATAGATTGCCTATACGACTGTTCCCTACTCTGTTTCTCTTCTCATTCACCTCCCTTGACTGTATCCAATCACCTCGCTCGCTGAATAAAGTTTTGCTTTCTGAAAGAACTGATGGTCGTTTTTTAAATATTTCTTACATGTTCATGGTAGTATGA	MNNCNLLNSQRTVEGAYCSNACVFSGMASILHVQAFPFSDSARNFNPQKYPEFFFLMGLIENSDEQAVRHAEGEGVGEVELTHRLPIRLFPTLFLFSFTSLDCIQSPRSLNKVLLSERTDGRFLNISYMFMVV	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANFNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYVVLNAIKK	34.73	gnl|BL_ORD_ID|2128|hsp_num:0	3316	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_2768 # 2245068 # 2245226 # 1 # ID=1_2768;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.491	scaffold_1_2768 	2245068	2245226	+	Strict	1200	20.7866	tetM	100.0	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCATTATGTACTTCCCATTGTACCTTCCGCCACCATCATCTTCCAGCTAGTCGTTACTCCGCATCTAAAAAGCTACAATTCTGGCGCTATAACAGAATGGCAGCATTCACTAGGGTGGCGCTACCTCGGCTCTGCCATGGATCTGAGGGTTCCATGA	MHYVLPIVPSATIIFQLVVTPHLKSYNSGAITEWQHSLGWRYLGSAMDLRVP	MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT	8.14	gnl|BL_ORD_ID|1596|hsp_num:0	1692	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1579 # 1280197 # 1280355 # 1 # ID=2_1579;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.516	scaffold_2_1579 	1280197	1280355	+	Strict	600	20.7866	THIN-B	100.0	3000851	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	THIN-B beta-lactamase	ATGTCCGCGATTTCTGTCCCAAAGACTACGCACGCCGTGCAGTTCCACAAGATTGGTGGACCTGAGGTGCTCGAGTTCAATGAAATTGATACCCCAGCACCCAAACCCGATGAGCTTCTTGTCAAGGTTGAATGGGGCGGCGTGAACTTTAGTGAGTGA	MSAISVPKTTHAVQFHKIGGPEVLEFNEIDTPAPKPDELLVKVEWGGVNFSE	MTLLAKLMLATVATMSAATVQAKTPAPKPDTPVDCDSCKAWNGEVTPFNVFGNTWYVGTAGLSAVLVTSPQGHVLLDGALPQSAPLIIANIAALGFRIEDVKFILNSHAHWDHAGGIAALQAASGATVVASASGALGLQSGTNGKDDPQFQAKPVVHVAKVEKVKVVGEGDAIKLGPLNLTAHMTPGHTPGATTWTWTSCEGQRCLDVVYADSLNPYSSGDFTYTGKGDGPDISASFAASIAKVAALPCDIILSVHPDSTGVLDKAAKRSGEHNPFIDANACRAYAATADAMLTKRLAKERGVALPAAAPAAQHAH	16.46	gnl|BL_ORD_ID|1309|hsp_num:0	1393	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_2140 # 1712119 # 1712250 # -1 # ID=2_2140;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.485	scaffold_2_2140 	1712119	1712250	-	Strict	600	21.1718	BRO-1	100.0	3004761	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BRO Beta-lactamase	ATGTTAGGACGCCAATTCTTGAACAGTTATCGGGCCGCTTTGGCGTATGTGGATACGCGTCGCGGCAGCTGGCACAGTAGTATAATTTATATGCAACGCAGACATTTTCTCGGGCCTAGAGACCATGTATAA	MLGRQFLNSYRAALAYVDTRRGSWHSSIIYMQRRHFLGPRDHV	MQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLDFKNQKDEIMAQIGKEIYPFL	13.74	gnl|BL_ORD_ID|2439|hsp_num:0	3565	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_212 # 180477 # 180725 # 1 # ID=7_212;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.498	scaffold_7_212 	180477	180725	+	Strict	550	21.557	VCC-1	100.0	3003713	protein homolog model	n/a	n/a	monobactam; carbapenem; penam	antibiotic inactivation	VCC beta-lactamase	ATGATCTGGGCCATTGAATGTATAGCAGTTGTCAAACGTCAGCTTGAGATCGGCGATCCACTCCTCAATACTGTAGTAGCGTTGGGCGGTCGGGCTGGGATCTGGTTTCGCGATATTAGAAGCTGCAAGCTTCTTTTCGACAGTGGAGAAATCCATTGGATGTTTGATGACGGATGGGTAGTGGGGGATTCCCAATGCCAAGTGGTCGACGGGGTGATTGAATGGCGCGGCATCTTTTTGTTTTCGTAG	MIWAIECIAVVKRQLEIGDPLLNTVVALGGRAGIWFRDIRSCKLLFDSGEIHWMFDDGWVVGDSQCQVVDGVIEWRGIFLFS	MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPLCSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQYSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVAESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDHAFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK	28.87	gnl|BL_ORD_ID|2070|hsp_num:0	2227	True	loose hit with at least 95 percent identity pushed strict
scaffold_9_758 # 612970 # 613266 # -1 # ID=9_758;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.492	scaffold_9_758 	612970	613266	-	Strict	950	26.5646	msrC	100.0	3002819	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGGTTCAACTCAAGATGGCACCGCGCGCAGAGCCAAAGAAAAAGCTCCCTGTTACCCTACTTTCAGGCTTCCTCGTGCGCCACCCCATATCCTGCACGACTGTAGAGTTTCTAACCGTTAGCATATTGCAGGGGAGTGGAAAAACTACTCTATTGGAGCATATCCTCCGTTCACCCGACCATGGGCTTAAAATTGCAGTTATCAGTATGCATATCATTTCCCCTCGCCCATTTGTCTGTGCGCTCCGTGTCTTGACGACTGTCTGGTTATCACCAAATAGTCAACGACATGGCTGA	MVQLKMAPRAEPKKKLPVTLLSGFLVRHPISCTTVEFLTVSILQGSGKTTLLEHILRSPDHGLKIAVISMHIISPRPFVCALRVLTTVWLSPNSQRHG	MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF	19.92	gnl|BL_ORD_ID|1937|hsp_num:0	2054	True	loose hit with at least 95 percent identity pushed strict
scaffold_9_803 # 645062 # 645202 # 1 # ID=9_803;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.454	scaffold_9_803 	645062	645202	+	Strict	400	20.0162	catA4	100.0	3004657	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGATATTACCATACTTGTTGCTGTTTATTCAGTACTGTGATGAAGGTCACCTCAAAGCACCCGCAATCAGCGGCGCCTCGCTAGAAGATGTGTGTCCGGTGATCGAGGATTTATTGTCAACTATCACGGCTCATCAATGA	MILPYLLLFIQYCDEGHLKAPAISGASLEDVCPVIEDLLSTITAHQ	MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK	21.20	gnl|BL_ORD_ID|2252|hsp_num:0	3357	True	loose hit with at least 95 percent identity pushed strict
scaffold_10_624 # 565666 # 565785 # -1 # ID=10_624;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.458	scaffold_10_624 	565666	565785	-	Strict	500	20.0162	OXA-92	100.0	3001632	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAATGCTACTATGGTCATTCGTGGGCAGAAAGCAGACTATGATGAATGGGTTAGACTTGGAAACGAAGGTTGGGGCTGGGATGATGTCCTTCCCCTTTTCAAAAAGGTGCTGTTGTGA	MNATMVIRGQKADYDEWVRLGNEGWGWDDVLPLFKKVLL	MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTLGDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGSVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	14.23	gnl|BL_ORD_ID|848|hsp_num:0	902	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_489 # 430804 # 430998 # -1 # ID=11_489;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.492	scaffold_11_489 	430804	430998	-	Strict	375	21.9422	fusC	100.0	3003733	protein homolog model	n/a	n/a	fusidic acid	antibiotic target protection	Target protecting FusB-type protein conferring resistance to Fusidic acid	ATGTCTAGCCTAACAGCAGCCCACAATGCAGTGTATGCGATCGAAGCAACTGTCCACGCCCCAAGCTTCGAGGGCATCTATGGAGAGATTTTCAAGGTTCTCAAGCCCGGTGGCGTCGTATGTCTAATAACGATCTTCGAAATTCCTCTCTTAACCCGTCCTATCCGTAGTTTGGTGTATACGAATGGGTTATGA	MSSLTAAHNAVYAIEATVHAPSFEGIYGEIFKVLKPGGVVCLITIFEIPLLTRPIRSLVYTNGL	MNKIEVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKDIDISDFITSIDDVKLTKKKAEHLLNELKVYIQDFEIPSSSQLEKIFRKVKKLKRPDINLIDTKEISYLGWNDNSSNRKYIVYKNLDDKFEGIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTYTKKGDYICYDSFKCNQNLDDINNLYEFIVKIK	30.19	gnl|BL_ORD_ID|2116|hsp_num:0	2250	True	loose hit with at least 95 percent identity pushed strict
scaffold_13_886 # 711904 # 712089 # -1 # ID=13_886;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.446	scaffold_13_886 	711904	712089	-	Strict	990	21.1718	farB	100.0	3003962	protein homolog model	n/a	n/a	antibacterial free fatty acids	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTACGGTTTTGTAGTCGTGAATGCGGTCAAGTACGCCTTGAACGCGGTTGACTGTCTCATTTACGAAGTACCAGTGCTAGGACCTATCCTTGGGCCGAGTTTGTTATGCTGTTTACTGCCAACTGTTACTCAAAGCGCTCAACAGTTCATTTACAGTCGTCTATTCCTTGAAATGCGTTATTGA	MYGFVVVNAVKYALNAVDCLIYEVPVLGPILGPSLLCCLLPTVTQSAQQFIYSRLFLEMRY	MDYPPLKGAALAWVTLSLGLAVFMEVLDTTIANVAVPVIAGNLGAATTQGTWVITSFSVANAVSVPLTGFLAKRIGEVKLFTAAAVGFVITSWLCGIAPNLQSLVVFRILQGFIAGPLIPLSQSLLMASYPPAKRTLALALWAMTVVVAPVLGPILGGWISGNWHWGWIFFINIPIGIISAWITWKHLKYRETETVKMPTDYVGLTLMVVGIGALQMMLDRGKELDWFASGEIITLGVVALVCLSYFIVWELGEKYPIVDLSLFKDRNFTVGVIATSLGFMVYMGTLTLLPLVLQTNLGYTSTWAGLAAAPVGILPVFLSPLIGRFGNKIDMRLFVTASFLTFAFTFYWRTDFYADMDIGNVIWPQFWQGVGVAMFFLPLTTITLSHMKGGQIAAAGSLSNFLRVLMGGVGVSVVSTLWERREALHHTRFAEHITPYSATLHETAAHLSQHGVSDIQTLGIINNTITQQGFIIGSNEIFMAGSLLFIIMIPVIWLAKPPFHNGGGGGH	12.01	gnl|BL_ORD_ID|2246|hsp_num:0	2429	True	loose hit with at least 95 percent identity pushed strict
scaffold_14_237 # 186948 # 187661 # -1 # ID=14_237;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.497	scaffold_14_237	186948	187661	-	Strict	89	93.9745	Trimethoprim-resistant dihydrofolate reductase DfrA43	37.7	3005345	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAGTACTTCCTTGACACTCATCGTAGCTGCGACCCGTACCAACGGAATTGGCATATCATCTCGAGGTCTCCCATGGCGTCTACCCCTCGAAATGGCCTATTTCGCGCGCGTTACTTCGAATGCTCCATCAGGTTCAAAGAATGTGGTCGTAATGGGCCGAAAGAGTTGGGAATCCATCCCCGCCAAATTCCGCCCGTTGAAGAACAGGTTAAACGTAGTTATCAGTGGGCAGACCGACTACGATCTGTATGTCTTCTATTCTCGGTCGCTGTTCAAGCAGGATTATGAAACTCCATCCACACGTAGCGGTTCGAATGCGGGGGACTCTATCCTTGCTTCTTCACTTCCTCAGGCACTCGCTAGTCTGCCAGAGCCAGCAGCCCCAAATACAACCGAAATTCATGGAACATTCATAATCGGAGGGGCCACCATATATTCTCAGTCCCTTTCCCTTTCCAAAACAGATCGAATCCTCCTCACACGAGTCCTTGAGCCCGCATTCGACGAGTGCGATGTATTCCTTCCCGAATTTCTACCCGACGAAGGACCACGAGAAGAAGCATCGTCAAGAACAGAGAACGTTGCATCACGACCGCGATGGACTAGGTCGAGCCACGAAGAGTTGGTTAATTGGGTTGGGTTCGATGTACCAAGTGGTATTCAAGAAGAGAAGGGAGTCAAGTACGAGTTTCAAATGTGGGTAAAATCATAG	MSTSLTLIVAATRTNGIGISSRGLPWRLPLEMAYFARVTSNAPSGSKNVVVMGRKSWESIPAKFRPLKNRLNVVISGQTDYDLYVFYSRSLFKQDYETPSTRSGSNAGDSILASSLPQALASLPEPAAPNTTEIHGTFIIGGATIYSQSLSLSKTDRILLTRVLEPAFDECDVFLPEFLPDEGPREEASSRTENVASRPRWTRSSHEELVNWVGFDVPSGIQEEKGVKYEFQMWVKS	MHMKMNIIVAMHEASRGIGINGELPWRIPEDMAHFARVTQKSVVIMGRKTWYSIPPKFRPLKNRLNIVLSRDPETRASIVSNTPGCMAFASLELCLQYLRQLHPSTIVFAIGGSSLYKEILAMQMLCERIYMTLVSGGPKTHSFDTFFPEIDETVYSKRICGGSGEHDDWKYKFVIYERPTSESVQSIETISQGH	121.54	gnl|BL_ORD_ID|3116|hsp_num:0	4077		
scaffold_14_399 # 320923 # 321129 # 1 # ID=14_399;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.541	scaffold_14_399 	320923	321129	+	Strict	500	21.1718	tetB(58)	100.0	3003981	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCGACCAGCGCTGCTGCTGCGTCCAAGTTATTCAAGCCGTATAGAGTCGGAGATGTTACGCTGTCGCATAGGGTGGTGATGGCGCCCCTTACACGATATCGCGCTGACGACCAGCATGTGCATCACGACGTTGCGGTCGAGTACTATCGGCAACGTTCTATTGTTCCGTACGTTCGATATCGTCCTGAAGGAGGACTGGACTGA	MSTSAAAASKLFKPYRVGDVTLSHRVVMAPLTRYRADDQHVHHDVAVEYYRQRSIVPYVRYRPEGGLD	MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFTYIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAPLAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGVIARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGTVGWDLTISLVGAAVIVAIFAPITVRAYMRRT	25.09	gnl|BL_ORD_ID|2311|hsp_num:0	2518	True	loose hit with at least 95 percent identity pushed strict
scaffold_16_731 # 598529 # 598777 # 1 # ID=16_731;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.550	scaffold_16_731 	598529	598777	+	Strict	500	22.3274	Escherichia coli ampH beta-lactamase	100.0	3004612	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGACCGTTTGTTGGGAGGCGGAGGAGGAGAGCGATGAGGTAGAAAGTGCAGAGCTAACACGCTGCGGTTTCGTTGGTACGGCCGTGTGTGTAGAAGCAGATGAGCCAGATGAGGCCGGGGATATAGCTCGATGTGCGTTCGAGCCCCCGACATCAGCATCATTTGGAGAAGCCGTAGCTCGAACGGGCTTCACTGGAGGAGGTGGTGGATTCATTGCCTGTGTGTGCAATGTTTTGAGTGAGGTGTAG	MTVCWEAEEESDEVESAELTRCGFVGTAVCVEADEPDEAGDIARCAFEPPTSASFGEAVARTGFTGGGGGFIACVCNVLSEV	MKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS	21.30	gnl|BL_ORD_ID|2079|hsp_num:0	3307	True	loose hit with at least 95 percent identity pushed strict
scaffold_17_705 # 594777 # 594932 # -1 # ID=17_705;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.513	scaffold_17_705 	594777	594932	-	Strict	380	20.7866	AcrS	100.0	3000656	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAAGTAATTCCAGTCTCTATTGTGATAAGAATTTGAGACGATACGAGCTAGGCCGCGGGGAACGCCCCAAGAGTGAACAACCGTTCCTTCCCTTTCTTCTTCTTGGTTTTGGCCCCGCGGGCAGCGTCTTCAATCCCCAGACTCTGCGTTGA	MTSNSSLYCDKNLRRYELGRGERPKSEQPFLPFLLLGFGPAGSVFNPQTLR	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM	23.18	gnl|BL_ORD_ID|488|hsp_num:0	520	True	loose hit with at least 95 percent identity pushed strict
scaffold_19_163 # 134500 # 134631 # -1 # ID=19_163;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	scaffold_19_163 	134500	134631	-	Strict	1300	21.9422	vanTC	100.0	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAATGCGTTTCGCGTACTCAGGCTAGGTCTTGATGAGAATGTTATCCCAAATCCATCTTACCCCAGTCGCCAACGTGTCATCGAAGCCATGGGTGACGTTTCGGTGCGCCTTCAAACGCTTCGAGTATAG	MNAFRVLRLGLDENVIPNPSYPSRQRVIEAMGDVSVRLQTLRV	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	6.16	gnl|BL_ORD_ID|692|hsp_num:0	734	True	loose hit with at least 95 percent identity pushed strict
scaffold_20_18 # 13327 # 13521 # 1 # ID=20_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.462	scaffold_20_18 	13327	13521	+	Strict	400	21.1718	IMP-32	100.0	3002223	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGAATAATTTTTCAACCATGGCCGCCCTTGTAGCTGCCCTCAATTCAACCCCTATTCGACGATTGAAGCGGACATGGGAGCAAGTTAGTCAGCGCAATCACAATATTTTAGATGACATCGAGAAGACGCTTCAGGTGAGACCGATTCCCATCATCTCCGGCATCGTGACTAGACTTGACATTTTGAATGGGTGA	MNNFSTMAALVAALNSTPIRRLKRTWEQVSQRNHNILDDIEKTLQVRPIPIISGIVTRLDILNG	MKKLFVLCVFFFCNIAVAEESLPDLKIEKLEEGVYVHTSFEEVKGWSVVTKHGLVVLVKNDAYLIDTPITAKDTEKLVNWFVERGYKIKGSISTHFHGDSTAGIEWLNSQSIPTYASELTNELLKKDNKVQAKHSFYGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPDGLGYLGDANLEAWPKSAKILMSKYGKAKLVVSSHSDIGDVSLLKRTWEQAVKGLNESKKSSQPSD	26.02	gnl|BL_ORD_ID|1824|hsp_num:0	1932	True	loose hit with at least 95 percent identity pushed strict
scaffold_24_419 # 361561 # 361698 # 1 # ID=24_419;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.464	scaffold_24_419 	361561	361698	+	Strict	940	20.0162	mdsC	100.0	3000791	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTACACGAAAAACATAATTACAAGGCCCGCTGCCGCATGCGAGCCCCGATTGTTCTTAGCGATGCATATACCTTGCCTGGAGGACTACCCATGATCAATGATACGATCGCATCCCGAGCAATTTTGATGTTTTGA	MLHEKHNYKARCRMRAPIVLSDAYTLPGGLPMINDTIASRAILMF	MRTALIRMISKHNDGNGIMKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG	8.95	gnl|BL_ORD_ID|1113|hsp_num:0	1180	True	loose hit with at least 95 percent identity pushed strict
scaffold_29_228 # 169305 # 169568 # 1 # ID=29_228;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.443	scaffold_29_228 	169305	169568	+	Strict	2200	23.0978	Bifidobacterium bifidum ileS conferring resistance to mupirocin	100.0	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGTTTTTAGAGCAGGCAAGAAATGTCATCATTAGAAGTGATCGACGGGGTTCTTTTGCTCGCGGAATTAGTTTCGTCTTATCGCAAATGGCAATCACGGTGTTCTCATGTTTTGAGTGGCCATATCTCTTTGCGAACTATTCAACGATCCGTACGACTACGGCGCTGATTGGAATTGCTTGGGTGGGCAGGGAACTATTAGGGGAGAAGAGTACTAGTGTTGGCTTCAACCTAGCTGTCTTGACAAACTGGTATATTAGATGA	MFLEQARNVIIRSDRRGSFARGISFVLSQMAITVFSCFEWPYLFANYSTIRTTTALIGIAWVGRELLGEKSTSVGFNLAVLTNWYIR	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	7.86	gnl|BL_ORD_ID|2107|hsp_num:0	2278	True	loose hit with at least 95 percent identity pushed strict
scaffold_35_130 # 112640 # 112804 # -1 # ID=35_130;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.485	scaffold_35_130 	112640	112804	-	Strict	890	21.9422	cpxA	100.0	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCCGTGGCCGTTATATGGTTTATGCCTTGCTATTCGTGTGGGTGGATATTGCTCTTGCAGTGATGAAGAGCTTCAAGATCTATGGGTGAGAGCTGGGAAGATCGATTTCAAGGCTATCTCAGTAGCCCCTAGTAGGCCAGTGAAGTACGCAATTGACTAG	MVPWPLYGLCLAIRVGGYCSCSDEELQDLWVRAGKIDFKAISVAPSRPVKYAID	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	11.82	gnl|BL_ORD_ID|136|hsp_num:0	152	True	loose hit with at least 95 percent identity pushed strict
scaffold_40_50 # 41399 # 41518 # -1 # ID=40_50;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.467	scaffold_40_50 	41399	41518	-	Strict	400	19.631	IND-5	100.0	3002261	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGACTGTTGACTCCACCCTACAGGCGCTCAAAGACTGGAAGGGCGGGGGACGGGACGCATGGTACATGTATTTGGACTTCACATATCTATTATTCTTTACTCAGGCTTATAGTACATAG	MTVDSTLQALKDWKGGGRDAWYMYLDFTYLLFFTQAYST	MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKKGVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSKTNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSNSATDLGYIKEANVEQWPITIDKLKAKYSKATLIIPGHDDWKGGGHVEHTLELLNKK	16.32	gnl|BL_ORD_ID|1232|hsp_num:0	1306	True	loose hit with at least 95 percent identity pushed strict
scaffold_46_2 # 3100 # 3240 # 1 # ID=46_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.447	scaffold_46_2 	3100	3240	+	Strict	1200	21.1718	tetT	100.0	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCTGCCTTTCACATTCCCTTATGTGTTTTGGGAGTTCAGAAATCAGGAATCAGTTTTGGAACTCGGTTCGAAAACTGAGATCGCGATCATCGTGATTGAAATGGAATTTAGAAGTCAGGCTCCGAACCCGGTTCCCTAG	MLPFTFPYVFWEFRNQESVLELGSKTEIAIIVIEMEFRSQAPNPVP	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	7.07	gnl|BL_ORD_ID|1921|hsp_num:0	2037	True	loose hit with at least 95 percent identity pushed strict
scaffold_47_132 # 106337 # 106432 # -1 # ID=47_132;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.448	scaffold_47_132 	106337	106432	-	Strict	500	19.631	OXA-388	100.0	3001574	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGATGTTCGGAAACCCTGAATGGGAAAAGAATGCCAACGTTAGACTCGATCCGGAGAACATCGCCAAGGTACTTACGCTTAAGGTTCTTTGA	MKMFGNPEWEKNANVRLDPENIAKVLTLKVL	MNIQALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKYLFNEAHTTGVLVIQQGQIQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	11.31	gnl|BL_ORD_ID|1318|hsp_num:0	1403	True	loose hit with at least 95 percent identity pushed strict
scaffold_51_151 # 143341 # 143481 # -1 # ID=51_151;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.440	scaffold_51_151 	143341	143481	-	Strict	1200	21.1718	tetT	100.0	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCTGCCTTTCACATTCCCTTATGTGTTTTGGGAGTTCAGAAATCAGGAATCAGTTTTGGAACTCGGTTCGAAAACTGAGATCGCGATCATCGTGATTGAAATGGAATTTAGAAGTCAGGCTCCGAACCCGGTTCCCTAG	MLPFTFPYVFWEFRNQESVLELGSKTEIAIIVIEMEFRSQAPNPVP	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	7.07	gnl|BL_ORD_ID|1921|hsp_num:0	2037	True	loose hit with at least 95 percent identity pushed strict
scaffold_56_148 # 133722 # 133877 # -1 # ID=56_148;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.506	scaffold_56_148 	133722	133877	-	Strict	2000	20.4014	Staphylococcus aureus mupA conferring resistance to mupirocin	100.0	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCACACTGTGATCAAAATTGTTCCGGCCCCGACATTTAAATTGAGTACTTGGGACGTGACTAGCTCGCATCTTATGTTGCTGGTCCGTCTCCTACAAGTACTGGCCGGTCATCTGGAAGCCATGCCCTCAGGCTTGAGTCTCCCTATGCTGTGA	MHTVIKIVPAPTFKLSTWDVTSSHLMLLVRLLQVLAGHLEAMPSGLSLPML	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	4.98	gnl|BL_ORD_ID|2125|hsp_num:0	2270	True	loose hit with at least 95 percent identity pushed strict
scaffold_66_102 # 90514 # 90738 # -1 # ID=66_102;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.520	scaffold_66_102 	90514	90738	-	Strict	900	21.557	MdtK	100.0	3001327	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGTCAGCCGTCCGTGTTACCGATCTACAATCGACAGGCTTACATGTGGCGGTCCGGCCCACTCTGGTCTGGGAAGAAACTCTTGGAACGGTCCCCGCCGCGGATCTCGGTCTTGTCGACCTAAACCTGCATCGACTGATATCTGGCCGTTGGTTGAGGACTGCAATTGTTCAAAAGTACAATGGTCAGACGGATATTGTCTCGGAAATCAGTGATATGCGATAG	MSAVRVTDLQSTGLHVAVRPTLVWEETLGTVPAADLGLVDLNLHRLISGRWLRTAIVQKYNGQTDIVSEISDMR	MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVVLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTKIPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNPALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGSKLLTQMFVAGMGTNVIAGNFIAFSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFAGLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWGCRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLISGRWLWRYPRVKRE	15.61	gnl|BL_ORD_ID|1651|hsp_num:0	1752	True	loose hit with at least 95 percent identity pushed strict
scaffold_79_106 # 106628 # 106876 # -1 # ID=79_106;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.490	scaffold_79_106 	106628	106876	-	Strict	550	21.557	VCC-1	100.0	3003713	protein homolog model	n/a	n/a	monobactam; carbapenem; penam	antibiotic inactivation	VCC beta-lactamase	ATGATCTGGGCCATTGAATGTATAGCAGTTGTCAAACGTCAGCTTGAGATCGGCGATCCACTCCTCAATACTGTAGTAGCGTTGGGCGGTCGGGCTGGGATCTGGTTTCGCGATATTAGAAGCTGCAAGCTTCTTTTCGACAGTGGAGAAATCCATTGGATGTTTGATGACGGATGGGTAGTGGGGGATTCCCAATGCCAAGTGGTCGACGGGGTGATTGAATGGCGCGGCATCTTTTTGTTTTCGTAG	MIWAIECIAVVKRQLEIGDPLLNTVVALGGRAGIWFRDIRSCKLLFDSGEIHWMFDDGWVVGDSQCQVVDGVIEWRGIFLFS	MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPLCSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQYSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVAESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDHAFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK	28.87	gnl|BL_ORD_ID|2070|hsp_num:0	2227	True	loose hit with at least 95 percent identity pushed strict
scaffold_95_63 # 56930 # 57094 # -1 # ID=95_63;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.479	scaffold_95_63 	56930	57094	-	Strict	890	21.9422	cpxA	100.0	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCCGTGGCCGTTATATGGTTTATGCCTTGCTATTCGTGTGGGTGGATATTGCTCTTGCAGTGATGAAGAGCTTCAAGATCTATGGGTGAGAGCTGGGAAGATCGATTTCAAGGCTATCTCAGTAGCCCCTAGTAGGCCAGTGAAATACGCAATTGACTAG	MVPWPLYGLCLAIRVGGYCSCSDEELQDLWVRAGKIDFKAISVAPSRPVKYAID	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	11.82	gnl|BL_ORD_ID|136|hsp_num:0	152	True	loose hit with at least 95 percent identity pushed strict
scaffold_101_121 # 117554 # 117691 # 1 # ID=101_121;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.471	scaffold_101_121 	117554	117691	+	Strict	940	20.0162	mdsC	100.0	3000791	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTACACGAAAAACATAATTACAAGGCCCGCTGCCGCATGCGAGCCCCGATTGTTCTTAGCGATGCATATACCTTGCCTGGGGGACTACCCATGATCAATGATACGATCGCATCCCGAGCAATTTTGATGTTTTGA	MLHEKHNYKARCRMRAPIVLSDAYTLPGGLPMINDTIASRAILMF	MRTALIRMISKHNDGNGIMKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG	8.95	gnl|BL_ORD_ID|1113|hsp_num:0	1180	True	loose hit with at least 95 percent identity pushed strict
scaffold_159_76 # 63004 # 63123 # -1 # ID=159_76;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.475	scaffold_159_76 	63004	63123	-	Strict	400	19.631	IND-5	100.0	3002261	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGACCGTTGACTCCACCCTACAGGCGCTCAAAGACTGGAAGGGCGGGGGACGGGACGCATGGTACATGTATTTGGACTTCACATATCTATTATTCTTTACTCAGGCTTATAGTACATAG	MTVDSTLQALKDWKGGGRDAWYMYLDFTYLLFFTQAYST	MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKKGVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSKTNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSNSATDLGYIKEANVEQWPITIDKLKAKYSKATLIIPGHDDWKGGGHVEHTLELLNKK	16.32	gnl|BL_ORD_ID|1232|hsp_num:0	1306	True	loose hit with at least 95 percent identity pushed strict
scaffold_168_40 # 37751 # 37891 # 1 # ID=168_40;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.447	scaffold_168_40 	37751	37891	+	Strict	1200	21.1718	tetT	100.0	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCTGCCTTTCACATTCCCTTATGTGTTTTGGGAGTTCAGAAATCAGGAATCAGTTTTGGAACTCGGTTCGAAAACTGAGATCGCGATCATCGTGATTGAAATGGAATTTAGAAGTCAGGCTCCGAACCCGGTTCCCTAG	MLPFTFPYVFWEFRNQESVLELGSKTEIAIIVIEMEFRSQAPNPVP	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	7.07	gnl|BL_ORD_ID|1921|hsp_num:0	2037	True	loose hit with at least 95 percent identity pushed strict
scaffold_216_60 # 38522 # 38767 # 1 # ID=216_60;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.451	scaffold_216_60 	38522	38767	+	Strict	2200	23.0978	Bifidobacterium bifidum ileS conferring resistance to mupirocin	100.0	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGTTATCATTAGAAGTGATCGACGGGGTTCTTTTGCTCGCGGAATTAGTTTCGTCTTATCGCAAATGGCAATCACGGTGTTCTCATGTTTTGGGTGGCCATATCTCTTCGCAAACTATTCAACGATCCGTACGTACGACTACGGCGCTGATTGGAATTGCTTGGGTGGGCAGGGAACTATTAGGGGAGAAGAGTACTAGTGTTGGCTTCAACCTAGCTGTCTTGACAAACTGGTATATTAGATGA	MLSLEVIDGVLLLAELVSSYRKWQSRCSHVLGGHISSQTIQRSVRTTTALIGIAWVGRELLGEKSTSVGFNLAVLTNWYIR	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	7.32	gnl|BL_ORD_ID|2107|hsp_num:0	2278	True	loose hit with at least 95 percent identity pushed strict
scaffold_223_19 # 11857 # 11979 # 1 # ID=223_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.423	scaffold_223_19 	11857	11979	+	Strict	450	19.631	SPM-1	100.0	3003793	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPM beta-lactamase	ATGTCAAGCGGCGAAAGCTTCAAGGCTGGAAATCTCTTTGATGTCAAAGGACTCGTTGCCGTAATCACTGGAGGTAATGAAATTTATGCGTTTGATCTACTCAATGTCGGTTTTACCGAATGA	MSSGESFKAGNLFDVKGLVAVITGGNEIYAFDLLNVGFTE	MNSPKSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAETWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNELVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLKKFDAKIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL	14.49	gnl|BL_ORD_ID|2131|hsp_num:0	2298	True	loose hit with at least 95 percent identity pushed strict
scaffold_236_17 # 9869 # 10090 # -1 # ID=236_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.491	scaffold_236_17 	9869	10090	-	Strict	800	21.557	lmrP	100.0	3003969	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCAGTATTTGGATGCAGATGCCATTCGGCGAGCTCCACTGCTCGAAATTAGCGCGCCAATATATTAATGTTGACATCATATCAATCCTTGTACACGTTGAGGCGAAGTCTTCGCTCAGCCTTCGCCAGTTGAACGAATCCAAGGCTGAGCAAGCAGTAGAGTACAAGCAGATCTTTATGGATGACTGCGAACGACATAGCGAGCGGACCCGCTGGTGA	MGSIWMQMPFGELHCSKLARQYINVDIISILVHVEAKSSLSLRQLNESKAEQAVEYKQIFMDDCERHSERTRW	MQEFLNLPKQIQLRQLVRFVTITLGSSIFPFMAMYYTTYFGTFWTGLLMMITSLMGFVGTLYGGHLSDALGRKKVIMIGSVGTTLGWFLTILANLPNAAIPWLTFAGILLVEIASSFYGPAYEAMLIDLTDESNRRFVYTINYWFINIAVMFGAGLSGLFYDHHFLALLVALLLVNVLCFGVAYYYFDETRPETHAFDHGKGLLASFQNYRQVFQDRAFVLFTLGAIFSGSIWMQMDNYVPVHLKLYFQPTAVLGFQVTSSKMLSLMVLTNTLLIVLFMTVVNKLTEKWKLLPQLVVGSLLFTLGMLLAFTFTQFYAIWLSVVLLTFGEMINVPASQVLRADMMDHSQIGSYTGFVSMAQPLGAILASLLVSVSHFTGPLGVQCLFVVIALLGIYFTVVSAKMKKV	17.98	gnl|BL_ORD_ID|2249|hsp_num:0	2435	True	loose hit with at least 95 percent identity pushed strict
scaffold_237_11 # 11649 # 11897 # 1 # ID=237_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.550	scaffold_237_11 	11649	11897	+	Strict	500	22.3274	Escherichia coli ampH beta-lactamase	100.0	3004612	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGACCGTTTGTTGGGAGGCGGAGGAGGAGAGCGATGAGGTAGAAAGTGCAGAGCTAACACGCTGCGGTTTCGTTGGTACGGCCGTGTGTGTAGAAGCAGATGAGCCAGATGAGGCCGGGGATATAGCTCGATGTGCGTTCGAGCCCCCGACATCAGCATCATTTGGAGAAGCCGTAGCTCGAACGGGCTTCACTGGAGGAGGTGGTGGATTCATTGCCTGTGTGTGCAATGTTTTGAGTGAGGTGTAG	MTVCWEAEEESDEVESAELTRCGFVGTAVCVEADEPDEAGDIARCAFEPPTSASFGEAVARTGFTGGGGGFIACVCNVLSEV	MKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS	21.30	gnl|BL_ORD_ID|2079|hsp_num:0	3307	True	loose hit with at least 95 percent identity pushed strict
scaffold_283_14 # 12139 # 12279 # -1 # ID=283_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.440	scaffold_283_14 	12139	12279	-	Strict	1200	21.1718	tetT	100.0	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCTGCCTTTCACATTCCCTTATGTGTTTTGGGAGTTCAGAAATCAGGAATCAGTTTTGGAACTCGGTTCGAAAACTGAGATCGCGATCATCGTGATTGAAATGGAATTTAGAAGTCAGGCTCCGAACCCGGTTCCCTAG	MLPFTFPYVFWEFRNQESVLELGSKTEIAIIVIEMEFRSQAPNPVP	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	7.07	gnl|BL_ORD_ID|1921|hsp_num:0	2037	True	loose hit with at least 95 percent identity pushed strict
scaffold_306_22 # 21715 # 21846 # -1 # ID=306_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	scaffold_306_22 	21715	21846	-	Strict	1300	21.9422	vanTC	100.0	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAATGCGTTTCGCGTACTCAGGCTAGGTCTTGATGAGAATGTTATCCCAAATCCATCTTACCCCAGTCGCCAACGTGTCATCGAAGCCATGGGTGACGTTTCGGTGCGCCTTCAAACGCTTCGAGTATAG	MNAFRVLRLGLDENVIPNPSYPSRQRVIEAMGDVSVRLQTLRV	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	6.16	gnl|BL_ORD_ID|692|hsp_num:0	734	True	loose hit with at least 95 percent identity pushed strict
scaffold_317_11 # 8931 # 9113 # 1 # ID=317_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.399	scaffold_317_11 	8931	9113	+	Strict	500	24.2534	ADC-58	100.0	3004618	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGAATAATTGTAATCTACTCAATAGTCAACGAACTGTTGAAGGAGCATATTGCTCAAATGCATGCGTTTTCTCAGGTATGGCTAGTATTCTCCATGTCCAAGCCTTCCCCTTCTCCGATAGTGGTAGAAATTTCAACCCCCAGAAGTATCCTGAATTTTTTTTTCTCATGGGCCTCTTATAG	MNNCNLLNSQRTVEGAYCSNACVFSGMASILHVQAFPFSDSGRNFNPQKYPEFFFLMGLL	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANFNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYVVLNAIKK	15.67	gnl|BL_ORD_ID|2128|hsp_num:0	3316	True	loose hit with at least 95 percent identity pushed strict
